openPR Logo
Press release

Rising Diabetes Prevalence And Its Impact On Eye Health Driver: A Major Catalyst in the Evolution of the Diabetic Macular Edema (DME) Market in 2025

03-25-2025 06:29 AM CET | Health & Medicine

Press release from: The Business Research Company

Diabetic Macular Edema (DME) Market

Diabetic Macular Edema (DME) Market

What combination of drivers is leading to accelerated growth in the diabetic macular edema (dme) market?
The increase in prevalence of diabetes is expected to drive the growth of the diabetic macular edema (DME) market. Diabetes leads to complications like DME, where retinal blood vessels leak fluid into the macula, causing swelling and impaired vision. With over half a billion people globally living with diabetes, a number that is projected to more than double by 2050, the need for effective treatments for diabetic-related eye conditions like DME is growing. As such, the increasing prevalence of diabetes is directly influencing the expansion of the DME market.

Get Your Diabetic Macular Edema (DME) Market Report Here:
https://www.thebusinessresearchcompany.com/report/diabetic-macular-edema-dme-global-market-report

What is the projected compound annual growth rate (CAGR) of the diabetic macular edema (dme) market from 2025 to 2034, and what factors influence it?
The diabetic macular edema (DME) market is growing steadily, rising from $4.67 billion in 2024 to $4.89 billion in 2025 at a CAGR of 4.7%. The historical growth factors include a rising prevalence of diabetes, an increase in edema-related disorders, a growing number of diabetic eye disease cases, an aging population, and a rise in blindness cases.

The diabetic macular edema (DME) market is expected to witness steady expansion, reaching $5.82 billion by 2029 at a CAGR of 4.4%. Growth will be driven by broader healthcare access, increased government funding for healthcare, greater awareness of diabetic complications, higher adoption of telemedicine for eye care, and the development of specialized diabetic eye care centers. Key industry trends include advancements in anti-VEGF therapies, the adoption of corticosteroid implants, improvements in drug delivery systems, innovations in retinal laser treatments, AI-driven diagnostic tools, and the growing use of minimally invasive surgical techniques.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21169&type=smp

How are the latest trends influencing the growth of the diabetic macular edema (dme) market?
In the diabetic macular edema (DME) treatment market, companies are focusing on advanced drug therapies to improve treatment outcomes for patients. In March 2022, Novartis AG, a Switzerland-based pharmaceutical company, received European Commission approval for Beovu to treat visual impairment due to DME. Based on Phase III KESTREL and KITE study results, Beovu showed comparable effectiveness to aflibercept in improving vision, with patients on a 12-week treatment schedule having fewer instances of retinal fluid.

What are the major segments of the diabetic macular edema (dme) market and their role in driving growth?
The diabetic macular edema (DME) market covered in this report is segmented -

1) By Treatment: Anti-VEGF Therapy, Corticosteroids, Laser Therapy, Surgical Intervention
2) By Disease Stage: Early Stage, Moderate Stage, Advanced Stage
3) By Patient Demographics: Adults, Elderly, Children
4) By Route Of Administration: Intravitreal Injection, Topical, Systemic
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Anti-VEGF Therapy: Monoclonal Antibodies, Recombinant Protein-Based Therapies
2) By Corticosteroids: Intravitreal Steroid Injections, Injectable Sustained-Release Corticosteroids
3) By Laser Therapy: Focal Laser Photocoagulation, Panretinal Photocoagulation
4) By Surgical Intervention: Vitrectomy, Membrane Peeling

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21169

Which regions are key players in the growth of the diabetic macular edema (dme) market?
North America was the largest region in the diabetic macular edema (DME) market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic macular edema (DME) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the diabetic macular edema (dme) market?
Major companies operating in the diabetic macular edema (DME) market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Novartis AG, Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals, Carl Zeiss Meditec AG, Bausch & Lomb, Santen Pharmaceutical Co. Ltd., Carl Zeiss AG, Topcon Corporation, Ypsomed AG, ARKRAY Inc, Hugel Inc., Optos plc, Noven Pharmaceuticals Inc., Alimera Sciences Inc., Allergan plc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21169&type=smp

What Is Covered In The Diabetic Macular Edema (DME) Global Market Report?

•Market Size Forecast: Examine the diabetic macular edema (dme) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the diabetic macular edema (dme) market for a structured understanding.
•Key Players Overview: Analyze major players in the diabetic macular edema (dme) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the diabetic macular edema (dme) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the diabetic macular edema (dme) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the diabetic macular edema (dme) market.
•Industry Challenges: Identify potential risks and obstacles affecting the diabetic macular edema (dme) market.
•Competitive Landscape: Review strategic developments in the diabetic macular edema (dme) market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Diabetes Prevalence And Its Impact On Eye Health Driver: A Major Catalyst in the Evolution of the Diabetic Macular Edema (DME) Market in 2025 here

News-ID: 3934693 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for DME

Dimethyl Ether (DME) Production Cost
Dimethyl ether (DME) is a versatile chemical compound gaining increasing attention as a clean fuel, aerosol propellant, and intermediate for chemical synthesis. With properties similar to liquefied petroleum gas and favorable combustion characteristics, DME is widely explored for applications in transportation fuels, power generation, domestic energy use, and petrochemical processing. Understanding the production cost of dimethyl ether requires examining its feedstock pathways, process technologies, energy requirements, and regulatory obligations. Request a
Dimethyl Ether (DME) & R-DME Market Expansion and Future Trends | 2025 To 2034 O …
The Global Dimethyl Ether (DME) & R-DME Market Size, Scope, and Forecast 2025-2034 report is now part of Exactitude Consultancy's Market Research collection. Industry experts and researchers provide an authoritative and concise analysis of the Dimethyl Ether (DME) & R-DME Market, covering key aspects such as growth drivers, challenges, restraints, developments, and opportunities. This report delivers a precise evaluation of shifting market dynamics and emerging trends. Additionally, it offers a
DME Service Solutions Partners with the AAHomecare
DME Service Solutions, a leader in providing B2B outsourcing solutions specializing in healthcare, is thrilled to announce its partnership with the American Association for Homecare (AAHomecare). This partnership allows DME Service Solutions to engage with a community dedicated to advancing quality care and operational efficiency in the homecare industry. AAHomecare has served the home medical equipment (HME) industry for nearly four decades, advocating for improved access to quality homecare products
Global Airport Ground DME Market Analysis (2020-2025)
Global Info Research offers a latest published report on Airport Ground DME Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Airport Ground DME Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Global Durable Medical Equipment (DME) Market Insights, Forecast
Durable Medical Equipment (DME) is a medical equipment that durable, can be used in the home and have at least 3 years of life expectancy. The prevalence of chronic conditions, such as heart disorders, cancer, gynecological disorders, and neurological disorder is on a rise, demand of long term care and hospitalization for treatment of these disorders is anticipated to facilitate the demand for durable medical equipment. The global Durable Medical
Durable Medical Equipment (DME) Global Market 2019
Press Release – 30 Jan 2019 Research and Development News -- . . Latest Update "Global Durable Medical Equipment (DME) Market By Type, By Therapeutic and monitoring Devices Type, By End User, By Region, By Country (2018 Edition) - Forecast to 2023-By Type (Personal Mobility devices, Therapeutic and Monitoring Devices, Medical Furniture, Others), By Sub-Type (Oxygen Equipment, Blood Sugar Monitors, Continuous Passive Motions, Nebulizers, Other Devices), By End User (Hospitals and Clinics,